Welcome to the

4th WFH Gene Therapy Round Table - Webinar Series

The WFH GTRT will continue the global dialogue on the expected challenges and opportunities that gene therapy for hemophilia will present. The focus of the 2021 webinar series will be shared decision making in the era of gene therapy. Different topics will be addressed, including: the importance of education and informed consent, individual risk-benefit analysis, and patient decision aids.

Dates:  March 18, 2021 * June 10, 2021 * September 16, 2021

Time: 9h00 - 13h00 Eastern



The 1st WFH Gene Therapy
Round Table


The 2nd WFH Gene Therapy
Round Table


WFH Gene Therapy Registry - Slide deck


Clinical Trial

Latest Publications


Core data set on safety, efficacy, and durability of hemophilia gene therapy for a global registry: Communication from the SSC of the ISTH


The critical need for postmarketing surveillance in gene therapy for haemophilia


Gene therapy to cure haemophilia: Is robust scientific inquiry the missing factor?